Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Centessa Pharmaceuticals (CNTA) Other financing activities (2022 - 2025)

Historic Other financing activities for Centessa Pharmaceuticals (CNTA) over the last 3 years, with Q2 2025 value amounting to $4.4 million.

  • Centessa Pharmaceuticals' Other financing activities changed N/A to $4.4 million in Q2 2025 from the same period last year, while for Sep 2025 it was -$5.7 million, marking a year-over-year change of. This contributed to the annual value of -$5.3 million for FY2024, which is N/A changed from last year.
  • Per Centessa Pharmaceuticals' latest filing, its Other financing activities stood at $4.4 million for Q2 2025.
  • Centessa Pharmaceuticals' Other financing activities' 5-year high stood at $4.4 million during Q2 2025, with a 5-year trough of -$5.3 million in Q4 2024.
  • Its 3-year average for Other financing activities is -$1.5 million, with a median of -$2.5 million in 2022.